Study reveals the adverse effects of prenatal exposure to ethylene oxide on fetal development

FHS
June 27, 2024
5:59 pm

A study led by the Barcelona Institute for Global Health (ISGlobal), a centre supported by the “la Caixa” Foundation, provides new evidence on the adverse effects of prenatal exposure to ethylene oxide (EO) on foetal development.

After eight years with Sanofi, Frank Nestle departs as CSO, global head of research

Sanofi’s CSO and global head of research Frank Nestle is leaving the company, a representative confirmed to Endpoints News Wednesday. Nestle first took over both

May 9, 2024

Optimi Health Announces Third and Final Tranche of CAD $1,000,000 Secured for Debt Financing | Psychedelic Invest

Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi Health” or the “Company”), a Canadian drug research and formulation company licensed by Health Canada

November 3, 2023

RNAConnect, Inc. formally launches to drive RNA analysis

RNAConnect, a pioneering life science reagent company, officially launches today, promising groundbreaking solutions for exploring the real-world diversity of RNA sequence and structure.

May 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.